|
|
|
|
|
|
|
|
|
Admirable Legacies
The recent flurry of Q1 earnings reports offer a unique opportunity to assess the real-time impacts of COVID-19 on the sector. Arda Ural reports
|
|
Virtual Events: Q&A with Jenna Sherlock of Veeva and Neel Edeling of Lunbeck
An extension of an article in the November issue of Pharmaceutical Executive titled "Turning the Corner: A New Era of Pharma Sales Comes into View," this Q&A session further addresses the pandemic-enhanced benefits of virtual events, both as incredible sources of information and education as well as a new digital tool for the evolving sales representative.
|
|
The Enduring Value of Pharma/Biotech Hybrid Sales Teams
How can pharma create solutions that are effective, can provide long-term value, and will actually be adopted by HCPs and patients?
|
|
Turning the Corner: A New Era of Pharma Sales Comes into View
It wasn’t long before sales reps realized they needed a new strategy to keep prospect pools flowing—18 months later, a mix of in-person and virtual meetings with healthcare professionals is emerging as the preferred approach moving forward.
|
|
THE PHARM EXEC PODCAST: EPISODE 95
|
|
CEOs Share Their Industry Outlook
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
|
|
|
Reuters Next — 12/1-12/3
Rare Disease Innovation & Partnering Summit
2021 — 12/6-12/10
Immuno-Oncology 360 — 2/16-2/18 /
|
|
ADVERTISEMENT
Networks Matter – Peer-to-Peer Relationships
Peer-to-Peer learning relationships, such as Thought Leader Networks, are critically important for successful adoption of medical innovations. Learn how these Networks, or the different types "communities", each play a unique and complementary role in the adoption process.
Listen Now
|
|
ADVERTISEMENT
Modeling Patient Dynamics for Commercial Forecasting
Thursday, November 18, 2021 at 11am EST | 8am PST | 5pm CET | 4pm GMT
Register Now
|
|
|
|
|
|
|
